Company Overview of GamidaGen
GamidaGen develops and sells molecular based diagnostic kits for genetic inherited disorders. GamidaGen was formerly a subsidiary of Healthcare Technologies Ltd. As a result of Healthcare Technologies Ltd's acquisition by NexGen Biofuels Ltd. on December 31, 2007, GamidaGen operates as a subsidiary of NexGen Biofuels Ltd.
Key Executives for GamidaGen
GamidaGen does not have any Key Executives recorded.
Similar Private Companies By Industry
|3PLW Ltd.||Middle East/Africa|
|Accelerated Evolution Biotechnologies Ltd||Middle East/Africa|
|Adante Ltd.||Middle East/Africa|
|Advanced Biotechnology Ltd.||Middle East/Africa|
|Advanced Medical Analysis (AMA) Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact GamidaGen, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.